BRAIN TUMOUR
The special field of interest of this group is the preclinical and clinical testing of new radiopharmaceuticals for nuclear medicine diagnostics of brain tumours using positron-emission-tomography (PET) and correlation with magnetic resonance imaging (MRI)
